Financial support and resources available for businesses impacted by COVID-19.

Support for businesses impacted by COVID-19.

Precision NanoSystems

Precision NanoSystems (PNI) provides end-to-end solutions for companies developing medicines in oncology, infectious diseases and rare diseases. PNI’s proprietary technologies include its NanoAssemblr microfluidic-based continuous flow manufacturing platform for the development and manufacture of nanoparticle drug delivery systems, and its lipid nanoparticle delivery technology for RNA medicines. PNI supports its clients with custom research projects through its Formulation Solutions service and clinical implementation through Clinical Solutions. With its lipid nanoparticle delivery system, NanoAssemblr technology and its extensive drug development expertise, PNI’s platform is ushering in the next wave of medicines in infectious diseases, cancer and rare diseases.

Investment year: 2019
Industry sector: Life sciences
Region: Prairies and West
Website
Follow Precision NanoSystems
BDC Venture Capital Partner

Joseph Regan

Managing Partner